Washington Drug Letter
April 30, 2012
| Vol.
44 No.
18
Dems Introduce Label-Change Bill for Generic-Drug Makers
Democrats in the House and Senate have introduced companion bills that would allow generic-drug makers to update safety warnings on labeling without waiting for the brand drug maker to do it first.
This article is viewable by subscribers only. To view this article, please select an option below.
|